Researchers measured six per- and polyfluoroalkyl substances (PFAS) in maternal serum collected at approximately 10–12 weeks' gestation from participants in the Glowing prospective cohort. The analytic sample included 217 complete-case mother–infant dyads after five participants were excluded because PFAS characterization failed. The study tested associations between maternal PFAS concentrations and several outcomes: gestational age, birth weight and length, and longitudinal measures of weight, length, fat mass, and fat-free mass across 11 repeated measures in the first two years of life. Linear regression, SuperImposition by Translation And Rotation growth-curve metrics, and quantile g-computation were the primary analytic approaches, as described by the authors.
Data indicated that higher first-trimester maternal PFOS and PFHxS concentrations were associated with shorter gestation in adjusted models. The authors reported an example estimate for PFOS (β = −0.198 weeks per doubling, 95% CI −0.368 to −0.028). PFHxS was also associated with lower birth weight (β = −0.048 kg, 95% CI −0.093 to −0.002) in the cohort. The study team observed that these associations with birth outcomes were present for several individual PFAS rather than being driven by the mixture as a whole. The paper’s methods note that investigators adjusted for maternal albumin and estimated glomerular filtration rate and that the reported associations remained after those adjustments.
The cohort showed sex-specific differences. Among male infants only, the study team observed associations of PFOS, PFHxS, PFOA, and PFNA with shorter gestational duration. In males, PFNA additionally associated with shorter birth length. The authors therefore reported a concentration of birth-outcome associations in the male subgroup, implying potential sex-dependent vulnerability to prenatal PFAS exposure in this sample. The preprint does not provide mechanistic data; it reports these sex-stratified statistical associations as observed in the Glowing cohort.
Longitudinal analyses through age two produced a different pattern of associations. The authors reported that PFBS was associated with lower postnatal weight and reduced growth intensity of fat-free mass. For female children, PFHxS was associated with smaller length and lower fat-free mass across follow-up. These associations emerged in repeated-measures and growth-curve analyses rather than at the single time point of birth, indicating that certain PFAS were linked to altered growth trajectories and lean mass accrual in early life within this cohort.
The team used quantile g-computation to model the joint effect of the six measured PFAS as a mixture. That joint six-PFAS mixture model did not show an association with the examined outcomes, according to the authors. Reported individual-PFAS associations were robust to adjustment for maternal albumin and estimated glomerular filtration rate, per the preprint. The paper does not, in the abstract, list additional sensitivity analyses or alternative adjustment sets beyond those specified; readers interested in full analytic detail should consult the main methods and supplementary material in the preprint.
This report is posted as a medRxiv preprint and has not undergone peer review; the authors explicitly note that it should not guide clinical practice. The preprint states that data are available upon reasonable request, subject to privacy and access regulations. The authors declared no competing interests and reported Institutional Review Board approval by the University of Arkansas for Medical Sciences with informed consent obtained from participants. The source did not enumerate other study limitations in the abstract beyond those implicit in preprint reporting; for a complete list of limitations and full methodological detail, the main text and supplementary files should be consulted. Unanswered questions documented in the preprint include whether the observed sex-specific patterns replicate in other cohorts and whether mechanisms can explain the divergent postnatal growth signals; these remain to be resolved in peer-reviewed follow-up work.